Evidence map›Paper›PMID 40607001›Full record

ArticleFrontiers in oncology2025

Diagnosis and treatment of renal neuroendocrine tumors: a case report and literature review.

ShiHui Wang, JiongMing Li, JieShun Yang, Pei Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

ShiHui WangThe Second Affiliated Hospital of Kunming Medical University, Kunming, China.
JiongMing LiThe Second Affiliated Hospital of Kunming Medical University, Kunming, China.
JieShun YangThe Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Pei LiThe Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal neuroendocrine tumors (NETs) are rare due to the absence of neuroendocrine cells in the kidney. Preoperative diagnosis is challenging often leading to misdiagnosis unnecessary nephrectomy. This study retrospectively analyzed three cases of renal NETs reviewing their diagnosis treatment processes. The first case involved a 46-year-old female presenting with lower abdominal pain diagnosed with a left renal NET (G2) post-surgery. The second case was a 56-year-old female with back pain diagnosed with a renal pelvic NET (G2) after laparoscopic nephroureterectomy. The third case was a 45-year-old female presenting with a palpable mass diagnosed with a right renal NET (G3) with liver metastases. All cases exhibited non-specific clinical presentations imaging findings highlighting the difficulty in preoperative diagnosis. Surgical resection was the primary treatment for non-metastatic cases while the metastatic case received a combination of surgical medical therapy. This study emphasizes the need for improved preoperative diagnostic methods to avoid aggressive surgical approaches to preserve renal units when possible. Further research is required to develop effective diagnostic tools treatment strategies for renal NETs.

Indexed as

case reportdiagnosisliterature reviewrenal neuroendocrine tumorstreatment

Identifiers

PMID40607001
PMCPMC12213506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.